BOF NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

BranchOut Food Inc. Common Stock · Consumer Defensive · Packaged Foods

Open interactive chart View report data
Latest close 3.91 USD
-1.0% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 5.0% above the Trend Line and sits at 59.6% of its 52-week range. The latest completed week returned -1.0%, after a -18.2% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal; earnings are due in 10d.

Setup score 39 out of 100
Latest Close 3.91 USD 31 Jul 2026
1W Return -1.0% latest completed week
4W Return -18.2% short-term follow-through
12W Return 15.0% quarterly tape
Trend Breadth 92.3% 48 of 52 weeks active
Volume Ratio 0.2x vs 13-week average
What is working
  • The trend backdrop is active with a 9-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 43.61% based on similar historical setup states.
  • 2 reversal markers appear in the recent smart-money tape.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.0% Latest completed week; four-week move -18.2%. Indicator stack 82/41 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.61% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 53/100 65 relevant articles in the latest sentiment read. Event risk 10d Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 5.0% above the Trend Line and sits at 59.6% of its 52-week range. The latest completed week returned -1.0%, after a -18.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.2x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6512-week average 0.55

12-week confirmation

Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.65Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -18.2% over four weeks, 15.0% over 12 weeks, and 76.1% over one year. The current trend has remained active for 9 consecutive weeks.

Performance by holding period

1W-1.0%
4W-18.2%
12W15.0%
26W31.2%
52W76.1%
Active trend streak9 weeks
Active weeks in one year48
Trend breadth92.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.02Latest activity-pressure read.
Pressure change-103.8%Four-week change in activity pressure.
Leadership10.25Latest relative-leadership reading.
RS change-68.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength13/100Blend of value, momentum, and quality. Underlying universe rank 88; rank 1 is best.
Value16/100Relative valuation strength. Underlying universe rank 85; rank 1 is best.
Quality1/100Profitability and accounting quality. Underlying universe rank 100; rank 1 is best.
Momentum90/100Medium-term price momentum. Underlying universe rank 11; rank 1 is best.
Growth87/100Revenue and earnings growth. Underlying universe rank 14; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
4.6x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-9.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
14.3%
Gross profit retained from each unit of revenue.
Operating margin
-48.1%
Operating profit retained from revenue.
Free-cash-flow margin
-47.8%
Free cash flow generated from revenue.
Return on invested capital
-37.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
59.4%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-11.0%
Net share repurchases relative to market value.
Shareholder yield
-11.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 65 relevant articles.

15 positive · 41 neutral · 9 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings10dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-25.5%Distance below the 52-week high.
13-week volatility8.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+31.9%Week of 20 Feb.
Worst week-23.4%Week of 6 Mar.
Latest week-1.0%Week of 31 Jul.

Shape of recent returns

Strong gains12
Modest gains1
Flat weeks0
Modest losses3
Sharp losses10
Recent vol8.1%13-week weekly-return volatility.
Base vol10.6%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew9.9% / -5.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape46/100

Trend, activity pressure, participation, and risk combine to a 46/100 tape read.

 Indicator analysis60/100

Latest 12-week confirmation: trend 10/12, activity pressure 5/12, relative leadership 9/12.

Activity pressure 0.65; 2 reversal markers Next-Week ExpectancyNegative 43.61%

Next-week expectancy is negative with a 43.61% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors26/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 87; Small Cap Core rank 87 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment53/100

Weighted news tone is neutral across 65 relevant articles.

BranchOut Food Inc. Revenue Breakdown – NASDAQ:BOF Insiders50/100

No recent insider transaction evidence is stored.

 Earnings10d

Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20263.91 USD-1.0%3.73 USD2.28 USD-0.0210.2587.1KOn
24 Jul 20263.95 USD-4.4%3.70 USD2.27 USD0.2612.6990.8KOn
17 Jul 20264.13 USD-4.0%3.68 USD2.26 USD0.5516.5492.1KOn
10 Jul 20264.30 USD-10.0%3.66 USD2.26 USD0.6416.78142.5KOn
3 Jul 20264.78 USD4.4%3.63 USD2.25 USD0.4132.70514.9KOn
26 Jun 20264.58 USD7.0%3.58 USD2.24 USD0.0529.08477.2KOn
19 Jun 20264.28 USD19.2%3.53 USD2.23 USD-0.3916.16660.9KOn
12 Jun 20263.59 USD-4.5%3.47 USD2.23 USD-0.720.83117.6KOn
5 Jun 20263.76 USD9.0%3.46 USD2.23 USD-0.698.531.5MOn
29 May 20263.45 USD9.2%3.43 USD2.22 USD-0.69-4.39128.9KOff
22 May 20263.16 USD-7.9%3.42 USD2.22 USD-0.49-9.45342.2KOff
15 May 20263.43 USD0.9%3.41 USD2.21 USD-0.20-0.20750.0KOn
8 May 20263.40 USD-5.8%3.37 USD2.20 USD0.16-1.11478.5KOn
1 May 20263.61 USD-4.2%3.32 USD2.19 USD0.3311.05310.1KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.